The outlook of companies tied to the drug's legacy presents a complex investment scenario . While the initial surge generated substantial gains, generic competition have significantly eroded sales . https://social40.com/story7201274/the-copyright-and-the-pharmaceutical-sector-a-speculative-opportunity